Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis (Q37661169)

21 August 2017

1 reference

title

Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis (English)

1 reference

21 August 2017

0 references

Armando Rojas

1

1 reference

21 August 2017

Hector Figueroa

series ordinal

2

1 reference

21 August 2017

Erik Morales

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

22 December 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

31

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

334-341

1 reference

Cancer-related inflammation

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Toll-like receptors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by the receptor for advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Identification, classification, and expression of RAGE gene splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The road to advanced glycation end products: a mechanistic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Toxicity of the AGEs generated from the Maillard reaction: on the relationship of food-AGEs and biological-AGEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Tumors sound the alarmin(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

HMGB1: a two-headed signal regulating tumor progression and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

RAGE signaling sustains inflammation and promotes tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Nuclear factor-kappaB activation: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Inflammation: gearing the journey to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The hypoxic tumour microenvironment and metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Regulation of the chemokine receptor CXCR4 by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Apoptosis and non-apoptotic deaths in cancer development and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

S100P promotes pancreatic cancer growth, survival, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Toll-like receptors in inflammation, infection and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Structural and functional insights into RAGE activation by multimeric S100B

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Multimerization and interaction of Toll and Spätzle in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Derangement of immune responses by myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Regulatory T cells in autoimmmunity*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Regulatory T cells: major players in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The tumor microenvironment and its role in promoting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4 CD25 T regulatory cell activities in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Endothelial-stromal interactions in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Tumor angiogenesis--a potential target in cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Advanced glycation and endothelial functions: a link towards vascular complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The role of endothelial progenitor cells in tumour vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The multifaceted roles of nitric oxide in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Gene polymorphisms, apoptotic capacity and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

p53 polymorphisms: cancer implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

Expansion of myeloid immune suppressor Gr CD11b cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGP322

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGP322

1 reference

21 August 2017

1 reference